ChemoFx® is a decision support tool designed to work with you as you formulate a treatment regimen for each of your patients, such as selecting between therapeutically equivalent regimens. A central element of the ChemoFx® process is the determination of non-investigational agents to be tested:

   • Agents are physician-selected based on their knowledge of the available chemotherapies
   • Individual drugs and combinations of up to 3 drugs can be tested
   • A range of agents from different chemotherapeutic classes can be tested including
     biological agents.

Your experience and knowledge of the patient are central to developing an appropriate panel of drugs to be tested. You may elect to select agents from Precision's standard panels by tumor type. Alternatively you may design a custom panel.